- Joined
- Jul 16, 2018
- Messages
- 312
In 2018, the FDA approved a total of 59 new molecular drugs, hitting a high record. The National Medical Products Administration (NMPA) also approved nearly 50 new drugs not listed in China, of which 6 were indigenous innovative products.
With the listing of new drugs, drug prices have become one of the focus of attention. At the end of the year, GoodRx released the "2018 American Most Expensive Drugs" ranking, listing 20 of the most expensive retail drugs. Most of them are used to treat rare genetic diseases, and some are used to treat common disease, such as pulmonary hypertension and hepatitis C.
GoodRx is a well-known prescription drug search price website in the United States, which changes the ecology of the US pharmaceutical supply chain by displaying the latest drug prices in real time and making drug prices more transparent.
Gilead, Shire and AbbVie are among a number of well-known pharmaceutical companies that have been shortlisted for the 2018 drug price review, with prices ranging from $300,000 to more than $600,000 a year. Among them, many pharmaceutical companies provide assistance for patients to help them afford drugs.
Here list you the top five expensive drugs in "2018 American Most Expensive Drugs"
Top of the list is Horizon's Actimmune, which is suitable for two rare diseases, chronic granulomatous disease (CGD) and severe malignant osteoporosis (SMO). As a regular in the “most expensive drug list”, Horizon priced it at $52,322 a month (an average of 12 injections per month).
Then followed by Daraprim, a drug used in the treatment of parasitic infections, sold by Vyera Pharmaceuticals (formerly Turing Pharmaceuticals). Despite rigorous scrutiny, the price of daraprin remains high, at a monthly cost of $45,000 (60 tablets per month).
Cinryze and Takhzyro, Shire's two drugs for hereditary angioedema (HAE), occupy the third and fourth place respectively, with a monthly price of $44,140. Cinryze was approved earlier, and patients usually need 16 vials a month. Takhzyro was approved in August 2018, requiring two vials per month ($22,070 per vial). Jefferies analysts estimated that Takhzyro's peak sales will reach $1.8 billion, making it the most expensive drug in the top ranking.
The fifth drug in the list is Chenodal, a drug for gallstones, sold by Retrophin. In 2014, Chenodal’s price increased 5 times. The monthly cost of Chenodal is $42,570 ($473 per tablet and patients usually need to take 90 tablets). Some patients need to take 210 tablets a month, which means his medical bills can run up to $100,000.
Having a healthy body means having enormous amounts of wealth. So guys, please face up to your own health problems and take good care of your body.
With the listing of new drugs, drug prices have become one of the focus of attention. At the end of the year, GoodRx released the "2018 American Most Expensive Drugs" ranking, listing 20 of the most expensive retail drugs. Most of them are used to treat rare genetic diseases, and some are used to treat common disease, such as pulmonary hypertension and hepatitis C.
GoodRx is a well-known prescription drug search price website in the United States, which changes the ecology of the US pharmaceutical supply chain by displaying the latest drug prices in real time and making drug prices more transparent.
Gilead, Shire and AbbVie are among a number of well-known pharmaceutical companies that have been shortlisted for the 2018 drug price review, with prices ranging from $300,000 to more than $600,000 a year. Among them, many pharmaceutical companies provide assistance for patients to help them afford drugs.
Here list you the top five expensive drugs in "2018 American Most Expensive Drugs"
Top of the list is Horizon's Actimmune, which is suitable for two rare diseases, chronic granulomatous disease (CGD) and severe malignant osteoporosis (SMO). As a regular in the “most expensive drug list”, Horizon priced it at $52,322 a month (an average of 12 injections per month).
Then followed by Daraprim, a drug used in the treatment of parasitic infections, sold by Vyera Pharmaceuticals (formerly Turing Pharmaceuticals). Despite rigorous scrutiny, the price of daraprin remains high, at a monthly cost of $45,000 (60 tablets per month).
Cinryze and Takhzyro, Shire's two drugs for hereditary angioedema (HAE), occupy the third and fourth place respectively, with a monthly price of $44,140. Cinryze was approved earlier, and patients usually need 16 vials a month. Takhzyro was approved in August 2018, requiring two vials per month ($22,070 per vial). Jefferies analysts estimated that Takhzyro's peak sales will reach $1.8 billion, making it the most expensive drug in the top ranking.
The fifth drug in the list is Chenodal, a drug for gallstones, sold by Retrophin. In 2014, Chenodal’s price increased 5 times. The monthly cost of Chenodal is $42,570 ($473 per tablet and patients usually need to take 90 tablets). Some patients need to take 210 tablets a month, which means his medical bills can run up to $100,000.
Having a healthy body means having enormous amounts of wealth. So guys, please face up to your own health problems and take good care of your body.